1-3 of 3
Fian K Mirea
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Role of Mcl-1 Expression and Phosphorlyation in Resistance to Chemotherapy and Kinase Inhibitors in FLT3-ITD-Positive Acute Myeloid Leukemia (AML)

Florian H Heidel, MD, Henning Schulze-Bergkamen, MD, Binje Vick, Daniel B Lipka, MD, Fian K Mirea, Toni Urbanik, Joseph T Opferman, PhD, Thomas Fischer, MD
Journal: Blood
Blood (2008) 112 (11): 220.
https://doi.org/10.1182/blood.V112.11.220.220
Published: 2008
Journal Articles

3,4-Diarylmaleimides Effectively Inhibit Proliferation of FLT3-ITD-Positive Leukemic Cells, Induce Apoptosis and Show Additive Effects in Combination with Chemotherapeutic Drugs.

Florian H. Heidel, MD, Daniel B. Lipka, MD, Fian K. Mirea, Boyka Markova, PhD, Christian Peifer, PhD, Jan-Peter Kramp, PhD, Stanislav Plutizki, Christoph Huber, MD, Gerd Dannhardt, PhD, Thomas Fischer, MD
Journal: Blood
Blood (2007) 110 (11): 1605.
https://doi.org/10.1182/blood.V110.11.1605.1605
Published: 2007
Journal Articles

Bis(1 H -indol-2yl)methanones Are Effective Inhibitors of Mutated FLT3 Tyrosine Kinase, Overcome Resistance to PKC412A In Vitro and Show Synergy with Chemotherapy.

Florian Heidel, Fian K. Mirea, Frank Breitenbucher, Stefan Dove, Christoph Huber, Frank D. Bohmer, Thomas Fischer
Journal: Blood
Blood (2006) 108 (11): 1369.
https://doi.org/10.1182/blood.V108.11.1369.1369
Published: 2006